Literature DB >> 22609487

Interleukin 6 and C-reactive protein in esophageal cancer.

Magdalena Groblewska1, Barbara Mroczko, Dorota Sosnowska, Maciej Szmitkowski.   

Abstract

Esophageal cancer (EC) is one of the most aggressive malignant tumors of the gastrointestinal tract. It is well known that cancer initiation and tumor development are closely linked with inflammation. C-reactive protein (CRP) and interleukin-6 (IL-6) are acute-phase proteins involved in cancer development. It was suggested that CRP and IL-6 play potential roles in the growth and progression of malignant tumors, including EC. The aim of the study was to describe the significance of IL-6 and CRP in the development of esophageal cancer and to assess the potential role of their serum levels as prognostic indicators of EC patient's survival.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22609487     DOI： 10.1016/j.cca.2012.05.009

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN： 0009-8981            Impact factor:   3.786


  23 in total

1.  Discovery, fine-mapping, and conditional analyses of genetic variants associated with C-reactive protein in multiethnic populations using the Metabochip in the Population Architecture using Genomics and Epidemiology (PAGE) study.

Authors:  Jonathan M Kocarnik; Melissa Richard; Misa Graff; Jeffrey Haessler; Stephanie Bien; Chris Carlson; Cara L Carty; Alexander P Reiner; Christy L Avery; Christie M Ballantyne; Andrea Z LaCroix; Themistocles L Assimes; Maja Barbalic; Nathan Pankratz; Weihong Tang; Ran Tao; Dongquan Chen; Gregory A Talavera; Martha L Daviglus; Diana A Chirinos-Medina; Rocio Pereira; Katie Nishimura; Petra Bužková; Lyle G Best; José Luis Ambite; Iona Cheng; Dana C Crawford; Lucia A Hindorff; Myriam Fornage; Gerardo Heiss; Kari E North; Christopher A Haiman; Ulrike Peters; Loic Le Marchand; Charles Kooperberg
Journal:  Hum Mol Genet       Date:  2018-08-15       Impact factor: 6.150

2.  Effect of early enteral nutrition on postoperative nutritional status and immune function in elderly patients with esophageal cancer or cardiac cancer.

Authors:  Guiping Yu; Guoqiang Chen; Bin Huang; Wenlong Shao; Guangqiao Zeng
Journal:  Chin J Cancer Res       Date:  2013-06       Impact factor: 5.087

3.  Circular RNAs With Efficacy in Preclinical In Vitro and In Vivo Models of Esophageal Squamous Cell Carcinoma.

Authors:  Ulrich H Weidle; Tatjana Sela; Ulrich Brinkmann; Jens Niewoehner
Journal:  Cancer Genomics Proteomics       Date:  2022 May-Jun       Impact factor: 4.069

Review 4.  Cachexia in patients with oesophageal cancer.

Authors:  Poorna Anandavadivelan; Pernilla Lagergren
Journal:  Nat Rev Clin Oncol       Date:  2015-11-17       Impact factor: 66.675

5.  Variation by stage in the effects of prediagnosis weight loss on mortality in a prospective cohort of esophageal cancer patients.

Authors:  S Shen; J L Araujo; N K Altorki; J R Sonett; A Rodriguez; K Sungur-Stasik; C F Spinelli; A I Neugut; J A Abrams
Journal:  Dis Esophagus       Date:  2017-09-01       Impact factor: 3.429

6.  Risk factors of early recurrence within 6 months after esophagectomy following neoadjuvant chemotherapy for resectable advanced esophageal squamous cell carcinoma.

Authors:  Naoya Yoshida; Yoshifumi Baba; Hironobu Shigaki; Kazuto Harada; Masaaki Iwatsuki; Yasuo Sakamoto; Yuji Miyamoto; Junji Kurashige; Keisuke Kosumi; Ryuma Tokunaga; Masayuki Watanabe; Hideo Baba
Journal:  Int J Clin Oncol       Date:  2016-06-02       Impact factor: 3.402

7.  Multiancestral analysis of inflammation-related genetic variants and C-reactive protein in the population architecture using genomics and epidemiology study.

Authors:  Jonathan M Kocarnik; Sarah A Pendergrass; Cara L Carty; James S Pankow; Fredrick R Schumacher; Iona Cheng; Peter Durda; José Luis Ambite; Ewa Deelman; Nancy R Cook; Simin Liu; Jean Wactawski-Wende; Carolyn Hutter; Kristin Brown-Gentry; Sarah Wilson; Lyle G Best; Nathan Pankratz; Ching-Ping Hong; Shelley A Cole; V Saroja Voruganti; Petra Bůžkova; Neal W Jorgensen; Nancy S Jenny; Lynne R Wilkens; Christopher A Haiman; Laurence N Kolonel; Andrea Lacroix; Kari North; Rebecca Jackson; Loic Le Marchand; Lucia A Hindorff; Dana C Crawford; Myron Gross; Ulrike Peters
Journal:  Circ Cardiovasc Genet       Date:  2014-03-12

8.  Association between the inflammatory biomarker, C-reactive protein, and the response to radiochemotherapy in patients with esophageal cancer.

Authors:  Harun Badakhshi; David Kaul; Kuai-LE Zhao
Journal:  Mol Clin Oncol       Date:  2016-01-28

Review 9.  Prognostic role of serum C-reactive protein in esophageal cancer: a systematic review and meta-analysis.

Authors:  Ying Huang; Ji-Feng Feng; Jin-Shi Liu; Qi-Xun Chen
Journal:  Ther Clin Risk Manag       Date:  2015-01-21       Impact factor: 2.423

10.  Serum C-reactive protein (CRP) as a simple and independent prognostic factor in extranodal natural killer/T-cell lymphoma, nasal type.

Authors:  Ya-Jun Li; Zhi-Ming Li; Yi Xia; Jia-Jia Huang; Hui-Qiang Huang; Zhong-Jun Xia; Tong-Yu Lin; Su Li; Xiu-Yu Cai; Zhi-Jun Wu-Xiao; Wen-Qi Jiang
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.